Search Results - "Zonnenberg, B. A."

Cognitive impairment in tuberous sclerosis complex is a multifactorial condition by JANSEN, F. E, VINCKEN, K. L, VAN HUFFELEN, A. C, VAN NIEUWENHUIZEN, O, ALGRA, A, ANBEEK, P, BRAAMS, O, NELLIST, M, ZONNENBERG, B. A, JENNEKENS-SCHINKEL, A, VAN DEN OUWELAND, A, HALLEY, D

“…In patients with tuberous sclerosis complex (TSC), associations between tuber number, infantile spasms, and cognitive impairment have been proposed. We…”
Get full text

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide by DUBBINK, H. J, TAAL, W, BOOGERD, W, GROENENDIJK, F. H, SILLEVIS SMITT, PA. E, DINJENS, W. N. M, VAN DEN BENT, M. J, VAN MARION, R, KROS, J. M, VAN HEUVEL, I, BROMBERG, J. E, ZONNENBERG, B. A, ZONNENBERG, C. B. L, POSTMA, T. J, GIJTENBEEK, J. M. M

“…Mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) have been implicated in tumorigenesis of gliomas. Patients with high-grade astrocytomas with IDH1…”
Get full text

A Phase II Trial of Imatinib Therapy for Metastatic Medullary Thyroid Carcinoma by de Groot, J. W. B., Zonnenberg, B. A., van Ufford-Mannesse, P. Quarles, de Vries, M. M., Links, T. P., Lips, C. J. M., Voest, E. E.

“…Context: Medullary thyroid carcinoma (MTC) metastasizes early in its clinical course. No effective systemic therapy is available. Generally (somatic or…”
Get full text

Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome by Pieterman, C. R. C., Schreinemakers, J. M. J., Koppeschaar, H. P. F., Vriens, M. R., Rinkes, I. H. M. Borel, Zonnenberg, B. A., Van Der Luijt, R. B., Valk, G. D.

“…Summary Objective  Effect of genetic screening on outcome in multiple endocrine neoplasia type 1 (MEN1) remains unclear. Expression of MEN1 is described using…”
Get full text

Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients by Beerepoot, L. V., Mehra, N., Vermaat, J. S. P., Zonnenberg, B. A., Gebbink, M. F. G. B., Voest, E. E.

“…Background: There is accumulating evidence from preclinical studies that circulating endothelial cells (CECs) play an important role in neovascularization and…”
Get full text

Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex by Adriaensen, M.E.A.P.M, Schaefer-Prokop, C.M, Duyndam, D.A.C, Zonnenberg, B.A, Prokop, M

“…Aim To determine the gender-specific prevalence of pulmonary cysts typical for lymphangioleiomyomatosis (LAM) in adult patients with known tuberous sclerosis…”
Get full text

Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations by JANSEN, F. E, BRAAMS, O, VAN NIEUWENHUIZEN, O, NELLIST, M, VINCKEN, K. L, ALGRA, A, ANBEEK, P, JENNEKENS-SCHINKEL, A, HALLEY, D, ZONNENBERG, B. A, VAN DEN OUWELAND, A, VAN HUFFELEN, A. C

“…The purpose of this study was to systematically analyze the associations between different TSC1 and TSC2 mutations and the neurologic and cognitive phenotype…”
Get full text

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature by Adriaensen, M. E. A. P. M., Schaefer-Prokop, C. M., Stijnen, T., Duyndam, D. A. C., Zonnenberg, B. A., Prokop, M.

“…Background and purpose:  To investigate the prevalence of subependymal giant cell ependymomas (SEGA) in patients with tuberous sclerosis complex (TSC)…”
Get full text

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse by Brada, M., Hoang-Xuan, K., Rampling, R., Dietrich, P-Y., Dirix, L. Y., Macdonald, D., Heimans, J. J., Zonnenberg, B. A., Bravo-Marques, J. M., Henriksson, R., Stupp, R., Yue, N., Bruner, J., Dugan, M., Rao, S., Zaknoen, S.

“…Background: Recurrent glioblastoma multiforme (GBM) is resistant to most therapeutic endeavors, with low response rates and survival rarely exceeding six…”
Get full text

Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases by Lam, M G E H, de Klerk, J M H, van Rijk, P P, Zonnenberg, B A

“…Many patients with cancer develop symptomatic skeletal metastases at an advanced stage of their disease. Skeletal metastases are often complicated by pain…”
Get more information

Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response by Rosenbaum, C. E. N. M., van den Hoven, A. F., Braat, M. N. G. J. A., Koopman, M., Lam, M. G. E. H., Zonnenberg, B. A., Verkooijen, H. M., van den Bosch, M. A. A. J.

“…Background Yttrium-90 radioembolization ( 90 Y-RE) as a treatment for liver tumours induces radiation damage and hypoxia in liver tissue, which is also a…”
Get full text

Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques by Nijsen, J F, Zonnenberg, B A, Woittiez, J R, Rook, D W, Swildens-van Woudenberg, I A, van Rijk, P P, van het Schip, A D

“…Since one of the most frequent sites of human metastatic cancer is the liver, particularly in colon and rectum carcinoma, there is a special need for the…”
Get full text

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy by VAN DEN BENT, M. J, KROS, J. M, PUNT, C. J. A, BOOGERD, W, HEIMANS, J. J, PRONK, L. C, VAN GROENINGEN, C. J, KROUWER, H. G. J, TAPHOORN, M. J. B, ZONNENBERG, B. A, TIJSSEN, C. C, TWIJNSTRA, A

Get full text

Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis by Vente, M. A. D., Wondergem, M., van der Tweel, I., van den Bosch, M. A. A. J., Zonnenberg, B. A., Lam, M. G. E. H., van het Schip, A. D., Nijsen, J. F. W.

“…Radioembolization with yttrium-90 microspheres ( 90 Y-RE), either glass- or resin-based, is increasingly applied in patients with unresectable liver…”
Get full text

High Rate of Mosaicism in Tuberous Sclerosis Complex by Verhoef, Senno, Bakker, Lida, Tempelaars, Anita M.P., Hesseling-Janssen, Arjenne L.W., Mazurczak, Tadeusz, Jozwiak, Sergiusz, Fois, Alberto, Bartalini, Gabriella, Zonnenberg, Bernard A., van Essen, Anthonie J., Lindhout, Dick, Halley, Dicky J.J., van den Ouweland, Ans M.W.

“…Six families with mosaicism are identified in a series of 62 unrelated families with a mutation in one of the two tuberous sclerosis complex (TSC) genes, TSC1…”
Get full text

PCV chemotherapy for recurrent glioblastoma multiforme by KAPPELLE, A. C, POSTMA, T. J, TAPHOORN, M. J. B, GROENEVELD, G. J, VAN DEN BENT, M. J, VAN GROENINGEN, C. J, ZONNENBERG, B. A, SNEEUW, K. C. A, HEIMANS, J. J

“…The authors evaluated response, time to progression (TTP), survival, prognostic factors, and toxicity in 63 patients with a recurrent glioblastoma multiforme…”
Get full text

A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma by Postma, T. J., Heimans, J. J., Luykx, S. A., van Groeningen, C. J., Beenen, L. F. M., Hoekstra, O. S., Taphoorn, M. J. B., Zonnenberg, B. A., Klein, M., Vermorken, J. B.

“…Background: The prognosis of malignant gliomas remains poor. In recurrent disease, chemotherapy can be considered. Patients and methods: In this phase II study…”
Get full text

Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems by Hartkamp, A, van Boxtel, A J, Zonnenberg, B A, Witteveen, P O

“…Totally implantable venous access devices (TIVADs) are valuable instruments in case prolonged intravenous therapy is required, but implantation and use of…”
Get more information

Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP by Lam, M G E H, Hoekstra, A, de Klerk, J M H, van Rijk, P P, Zonnenberg, B A

“…The radiation exposure to bystanders from 89SrCl2, 186Re-HEDP and 153Sm-EDTMP, is generally thought to be caused by "bremsstrahlung" and gamma-radiation, with…”
Get more information

‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1 by van Beek, Dirk-Jan, van Leeuwaarde, Rachel S, Pieterman, Carolina R C, Vriens, Menno R, Valk, Gerlof D

“…Rare diseases pose specific challenges in the field of medical research to provide physicians with evidence-based guidelines derived from studies with…”
Get full text